IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Hudson Executive Capital LP

Q2 2017 Holdings

Filed 2017-08-14 | 7 holdings | $45.2M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Atricure Inc(ATRC)COM04963C209$45.0M1,855,00099.6%
Eagle Pharmaceuticals Inc(EGRX)COM269796108$75.0K950,6000.2%
CIT Group Inc(CITUSD)COM NEW125581801$52.2K1,070,8570.1%
Corindus Vascular Robotics I(CVRSEUR)COM218730109$21.1K11,336,1540.0%
Acorda Therapeutics IncCOM00484M106$15.2K773,0900.0%
Magellan Health IncCOM NEW559079207$7.2K98,7000.0%
Meridian Bioscience Inc(MR4)COM589584101$1.9K123,3000.0%